Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses

Menglin Wang¹, Benoit Rousseau², Kunyu Qiu¹, Guannan Huang^{3

4

5}, Yu Zhang¹, Hang Su⁶, Christine Le Bihan-Benjamin⁷, Ines Khati⁷, Oliver Artz², Michael B Foote², Yung-Yi Cheng⁸, Kuo-Hsiung Lee^{8

9}, Michael Z Miao^{10

11}, Yue Sun¹², Philippe-Jean Bousquet¹³, Marc Hilmi^{14

15}, Elise Dumas^{16

17

18}, Anne-Sophie Hamy^{16

19}, Fabien Reyal^{16

20

21}, Lin Lin²², Paul M Armistead^{22

23}, Wantong Song^{24

25}, Ava Vargason¹, Janelle C Arthur^{3

5

26}, Yun Liu¹, Jianfeng Guo¹, Xuefei Zhou¹, Juliane Nguyen¹, Yongqun He^{27

28

29}, Jenny P-Y Ting^{3

4

5

30}, Aaron C Anselmo¹, Leaf Huang³¹

Affiliations

¹ Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
² Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
³ Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
⁴ Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.
⁵ Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA.
⁶ Department of Bioinformatics and Computational Biology, University of North Carolina, Chapel Hill, NC, USA.
⁷ Health Data and Assessment Department, Data Science and Assessment Division, French National Cancer Institute, Boulogne-Billancourt, France.
⁸ Natural Products Research Laboratories, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
⁹ Chinese Medicine Research and Development Center, China Medical University and Hospital, Taichung, Taiwan.
¹⁰ Curriculum in Oral and Craniofacial Biomedicine, Division of Oral and Craniofacial Health Sciences, Adams School of Dentistry, University of North Carolina, Chapel Hill, NC, USA.
¹¹ Thurston Arthritis Research Center, Division of Rheumatology, Allergy, and Immunology, University of North Carolina, Chapel Hill, NC, USA.
¹² Department of Radiology and Biomedical Research Imaging Center, University of North Carolina, Chapel Hill, NC, USA.
¹³ Health Survey, Data Science and Assessment Division, French National Cancer Institute, Boulogne Billancourt, France.
¹⁴ GERCOR Group, Paris, France.
¹⁵ Medical Oncology Department, Curie Institute, Saint Cloud, France.
¹⁶ Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France.
¹⁷ INSERM, U900, Paris, France.
¹⁸ MINES ParisTech, PSL Research University, CBIO-Centre for Computational Biology, Paris, France.
¹⁹ Department of Medical Oncology, Centre René Hughenin, Saint Cloud, France.
²⁰ Department of Surgery, Institut Jean Godinot, Reims, France.
²¹ Department of Surgical Oncology, Institut Curie, University of Paris, Paris, France.
²² BMTCT Program, Division of Hematology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
²³ Department of Internal Medicine, University of North Carolina, Chapel Hill, NC, USA.
²⁴ Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China.
²⁵ Jilin Biomedical Polymers Engineering Laboratory, Changchun, China.
²⁶ Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, NC, USA.
²⁷ Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
²⁸ Unit for Laboratory Animal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
²⁹ Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA.
³⁰ Division of Craniofacial and Surgical Care, School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
³¹ Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. leafh@email.unc.edu.

PMID: 37749267
DOI: 10.1038/s41587-023-01957-8

Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses

Menglin Wang et al. Nat Biotechnol. 2024 Aug.

. 2024 Aug;42(8):1263-1274.

doi: 10.1038/s41587-023-01957-8. Epub 2023 Sep 25.

Authors

Affiliations

¹ Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
² Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
³ Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
⁴ Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.
⁵ Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA.
⁶ Department of Bioinformatics and Computational Biology, University of North Carolina, Chapel Hill, NC, USA.
⁷ Health Data and Assessment Department, Data Science and Assessment Division, French National Cancer Institute, Boulogne-Billancourt, France.
⁸ Natural Products Research Laboratories, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
⁹ Chinese Medicine Research and Development Center, China Medical University and Hospital, Taichung, Taiwan.
¹⁰ Curriculum in Oral and Craniofacial Biomedicine, Division of Oral and Craniofacial Health Sciences, Adams School of Dentistry, University of North Carolina, Chapel Hill, NC, USA.
¹¹ Thurston Arthritis Research Center, Division of Rheumatology, Allergy, and Immunology, University of North Carolina, Chapel Hill, NC, USA.
¹² Department of Radiology and Biomedical Research Imaging Center, University of North Carolina, Chapel Hill, NC, USA.
¹³ Health Survey, Data Science and Assessment Division, French National Cancer Institute, Boulogne Billancourt, France.
¹⁴ GERCOR Group, Paris, France.
¹⁵ Medical Oncology Department, Curie Institute, Saint Cloud, France.
¹⁶ Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France.
¹⁷ INSERM, U900, Paris, France.
¹⁸ MINES ParisTech, PSL Research University, CBIO-Centre for Computational Biology, Paris, France.
¹⁹ Department of Medical Oncology, Centre René Hughenin, Saint Cloud, France.
²⁰ Department of Surgery, Institut Jean Godinot, Reims, France.
²¹ Department of Surgical Oncology, Institut Curie, University of Paris, Paris, France.
²² BMTCT Program, Division of Hematology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
²³ Department of Internal Medicine, University of North Carolina, Chapel Hill, NC, USA.
²⁴ Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China.
²⁵ Jilin Biomedical Polymers Engineering Laboratory, Changchun, China.
²⁶ Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, NC, USA.
²⁷ Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
²⁸ Unit for Laboratory Animal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
²⁹ Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA.
³⁰ Division of Craniofacial and Surgical Care, School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
³¹ Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. leafh@email.unc.edu.

PMID: 37749267
DOI: 10.1038/s41587-023-01957-8

Abstract

Increasing evidence implicates the tumor microbiota as a factor that can influence cancer progression. In patients with colorectal cancer (CRC), we found that pre-resection antibiotics targeting anaerobic bacteria substantially improved disease-free survival by 25.5%. For mouse studies, we designed an antibiotic silver-tinidazole complex encapsulated in liposomes (LipoAgTNZ) to eliminate tumor-associated bacteria in the primary tumor and liver metastases without causing gut microbiome dysbiosis. Mouse CRC models colonized by tumor-promoting bacteria (Fusobacterium nucleatum spp.) or probiotics (Escherichia coli Nissle spp.) responded to LipoAgTNZ therapy, which enabled more than 70% long-term survival in two F. nucleatum-infected CRC models. The antibiotic treatment generated microbial neoantigens that elicited anti-tumor CD8⁺ T cells. Heterologous and homologous bacterial epitopes contributed to the immunogenicity, priming T cells to recognize both infected and uninfected tumors. Our strategy targets tumor-associated bacteria to elicit anti-tumoral immunity, paving the way for microbiome-immunotherapy interventions.

PubMed Disclaimer

Comment in

Targeting tumour-associated bacteria.
Crunkhorn S. Crunkhorn S. Nat Rev Drug Discov. 2023 Dec;22(12):955. doi: 10.1038/d41573-023-00176-9. Nat Rev Drug Discov. 2023. PMID: 37907753 No abstract available.
Bacterial antigens unleash tumor-targeting immunity.
Boeck N, Trajanoski Z, Galluzzi L. Boeck N, et al. Cell Host Microbe. 2023 Dec 13;31(12):1945-1947. doi: 10.1016/j.chom.2023.11.001. Cell Host Microbe. 2023. PMID: 38096784 Free PMC article.

References

1. Nat Med. 2022 Apr;28(4):713-723 - PubMed
1. J Biomed Biotechnol. 2010;2010:297505 - PubMed
1. Nature. 2021 Apr;592(7852):138-143 - PubMed
1. Nat Biomed Eng. 2019 Sep;3(9):717-728 - PubMed
1. Nat Commun. 2018 Jun 8;9(1):2237 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses

Affiliations

Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses

Authors

Affiliations

Abstract

Comment in

References

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Research Materials

Miscellaneous